Loïc Y.
- Country
- France
- Department
- Hematologie
Research Overview
- Phase 1 Study of JNJ-80948543, a T-cell Redirecting Antibody, in Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients
- TRANSCRIPT: An open label, controlled, randomized multicentric international study evaluating the benefit of autologous stem cell transplantation after complete response in frontline setting patients with T cell-lymphoma
- Phase I Evaluation of ABBV-525, a MALT1 Inhibitor, in Patients with B-Cell Malignancies
Data & Insights
Has run more than one trial at 196 of 378 partner sites.
Specializations
Lymphoma Research
The investigator specializes in the treatment of various B-cell and T-cell lymphomas, with particular focus on diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). Their research encompasses both newly diagnosed and relapsed/refractory disease states.
- Peripheral T-cell lymphoma
- Burkitt lymphoma
- Marginal zone lymphoma
- Richter transformation
Leukemia Studies
The investigator conducts extensive research in chronic lymphocytic leukemia (CLL) and related conditions. Their work includes studies of novel therapeutic combinations and treatment strategies for both treatment-naïve and relapsed patients.
- Large granular lymphocytic leukemia
- Hairy cell leukemia
- Small lymphocytic lymphoma
Therapeutic Approaches
The investigator explores innovative treatment modalities including bispecific antibodies, CAR T-cell therapy, and targeted combinations. Their research focuses on developing personalized treatment strategies using novel therapeutic agents.
- Immunotherapy combinations
- BTK inhibitors
- Venetoclax-based regimens
- Fixed-duration approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.